2018
Krassowski M, Paczkowska M, Cullion K, Huang T, Dzneladze I, Ouellette F, Yamada JT, Fradet-Turcotte A, Reimand J (2018) ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins. NAR46(D1):D901-D910
Canny MD, Moatti N, Wan LC, Fradet-Turcotte A, Orthwein A, Juang Y, Zhang W, Noordermeer SM, Wilson MD, Vorybov A, Ernst A, Ng TF, Zimmermann M, Munro M, Sidhu SS, Sicheri F and Durocher D (2018) A genetically encoded inhibitor of 53BP1 to stimulate homology-based gene editing.Nature Biotech., 36(1):95-102
2017
Kitevski-LeBlanc J*, Fradet-Turcotte A*, Kukic P, Portella G, Yuwen T, Wilson MD, Panier S, Duan S, Canny MD, van Ingen H, Arrowsmith C, Rubinstein JL, Vendruscolo M, Durocher D and Kay LE (2017) The RNF168 paralog RNF169 defines a new class of ubiquitylated-histone reader involved in the response to DNA damage. eLife, 6. pii: e23872 [*co-first author]
2016
Fradet-Turcotte A*, Sitz J, Grapton D and Orthwein A*. (2016) BRCA2 functions: from DNA repair to replication fork stabilization. Endocr Relat Cancer, 23(10):T1-T17 [*co-corresponding author]
Wilson MD*, Benlekbir S*, Fradet-Turcotte A, Sherker A, Julien JP, McEwan A, Noordermeer SM, Sicheri F, Rubinstein JL, Durocher D. (2016) The structural basis of modified nucleosome recognition by 53BP1. Nature, 536(7614):100-3 [*co-first author]
Canny MD, Wan LC, Fradet-Turcotte A, Orthwein A, Juang Y, Zhang W, Moatti N, Noordermeer SM, Wilson MD, Vorybov A, Ernst A, Ng TF, Zimmermann M, Munro M, Sidhu SS, Sicheri F and Durocher D. (2016) A genetically encoded inhibitor of 53BP1 to stimulate homology-based gene editing. bioRxiv, doi:10.1101/060954
Jacquet K, Fradet-Turcotte A, Avvakumov N, Lambert JP, Roques C, Pandita RK, Paquet E, Herst P, Gingras AC, Pandita TK, Legube G, Doyon Y, Durocher D, Côté J. (2016) The TIP60 complex regulates bivalent chromatin recognition by 53BP1 through direct H4K20me binding and H2AK15 acetylation. Mol. Cell., 62(3):409-21
2015
Hart T, Chandrashekhar M, Aregger M, Steinhart Z, Brown KR, MacLeod G, Mis M, Zimmermann M, Fradet-Turcotte A, Sun S, Mero P, Dirks P, Sidhu S, Roth FP, Rissland OS, Durocher D, Angers S, Moffat J. (2015) High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell, 163(6):1515-26
2014
Orthwein A, Fradet-Turcotte A, Noordermeer SM, Canny MD, Brun CM, Strecker J, Escribano-Diaz C and Durocher D. (2014) Suppression of DNA double-strand break repair in mitosis paradoxically preserves genomic integrity. Science, 344(6180):189-93
2013
Bohgaki M, Bohgaki T, El Ghamrasni S, Srikumar T, Maire G, Panier S, Fradet-Turcotte A, Stewart GS, Raught B, Hakem A and Hakem R. (2013) RNF168 ubiquitylates 53BP1 and controls its response to DNA double-strand breaks. Proc Natl Acad Sci U S A., 110(52):20982-7
Fradet-Turcotte A, Canny MD, Escribano-Díaz C, Orthwein A, Leung CCY, Huang H, Landry MC, Kitevski-LeBlanc J, Noordermeer SM, Sicheri F and Durocher D. (2013) 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature, 499(7456):50-54
Escribano-Díaz C, Orthwein A, Fradet-Turcotte A, Xing M, Young JT, Tkáč J, Cook MA, Rosebrock AP, Munro M, Canny MD, Xu D and Durocher D. (2013) A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol. Cell., 49(5):872-83
Panier S, Ichijima Y, Fradet-Turcotte A, Leung CC, Kaustov L, Arrowsmith CH and Durocher D. (2012) Tandem protein interaction modules organize the ubiquitin-dependent response to DNA double-strand breaks. Mol. Cell., 47(3):383-95
2018
Weitzman MD* and Fradet-Turcotte A*. (2018) Virus DNA Replication and the host DNA damage response. Ann. Rev. Virol., In Press [*co-corresponding author - Review]
Ho T, Sitz J, Shen Q, Leblanc-Lacroix A, Campos E, Borozan I, Marcon E, Greenblatt J, Fradet-Turcotte A, Jin D and Frappier L (2018) A Screen for Epstein-Barr Virus Proteins that Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein. J. Virol., In Press
2015
Gagnon D, Fradet-Turcotte A. and Archambault J. (2015) A quantitative and high-throughput assay of human papillomavirus DNA replication. Methods Mol Biol., (1249):305-16
Lehoux M, Fradet-Turcotte A. and Archambault J. (2015) Methods to assess the nucleocytoplasmic shuttling of the HPV E1 helicase and its effects on cellular proliferation and induction of a DNA damage response. Methods Mol Biol., (1249):67-80
2012
Lehoux M, Fradet-Turcotte A, Lussier-Price M, Omichinski JG and Archambault J. (2012) Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide. J. Virol., 86(7):3486-500
2011
Fradet-Turcotte A, Bergeron-Labrecque F, Lehoux M, Moody CA, Laimins LA and Archambault J. (2011) Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J. Virol., 85(17): 8996-9012
Meinke G, Phelan P, Fradet-Turcotte A, Archambault J and Bullock PA. (2011) Structure-based design of a disulfide-linked oligomeric form of the Simian Virus 40 (SV40) large T antigen DNA-binding domain. Acta Crystallographica Section D: Biological Crystallography, 67(6):560-567
D’Abramo CM, Fradet-Turcotte A, and Archambault J. (2011) Chapter 11: Human Papillomavirus DNA replication: Insights into the structure and regulation of a eukaryotic DNA replisome. In "Small DNA Tumour Viruses", Ed. Kevin Gaston, Horizon Press.
Morin G*, Fradet-Turcotte A*, Bergeron-Labrecque F, Di Lello P, Omichinski JG and Archambault J. (2011) A conserved amphipathic helix in the N-terminal regulatory region of the papillomavirus E1 helicase is required for efficient viral DNA replication. J. Virol., 85(11):5287-5300 [*co-premier auteur]
Meinke G, Phelan P, Fradet-Turcotte A, Bohm A, Archambault A and Bullock PA. (2011) Structure-based analysis of the interaction between SV40 T-antigen origin binding domain and single stranded DNA. J. Virol., 85(2):818-27
2010
Fradet-Turcotte A, Moody CA, Laimins LA and Archambault J. (2010) Nuclear export of HPV31 E1 is regulated by Cdk2 phosphorylation and required for viral genome maintenance. J. Virol., 84(22): 11747-11760
Fradet-Turcotte A*, Morin G*, Lehoux M, Bullock PA, and Archambault J. (2010) Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication. Virology, 399(1):65-76 [*co-premier auteur]
2009
Fradet-Turcotte A, Brault K, Titolo S, Howley PM and Archambault J. (2009) Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9. Virology, 395(2):190-201
Gagnon G, Joubert S, Sénéchal H, Fradet-Turcotte A, Torre S and Archambault J. (2009) Proteasomal Degradation of the Papillomavirus E2 Protein is Modulated by Complex Formation with the Bromodomain-Containing Protein 4 (Brd4). J. Virol., 83(9):4127-39
2008
Côté-Martin A, Moody CA, Fradet-Turcotte A, D'abramo C, Lehoux M, Joubert S, Poirier G, Laimins LA, Coulombe B, Archambault J. (2008) The Human Papillomavirus E1 Helicase Interacts with the WD Repeat Protein p80 to Promote Maintenance of the Viral Genome in Keratinocytes. J Virol., 82(3):1271-83
2007
Moody CA, Fradet-Turcotte A, Archambault J and Laimins LA. (2007) Human Papillomaviruses Activate Caspases upon Epithelial Differentiation to Promote Genome Amplification through Cleavage of the E1 Replication Protein. Proc Natl Acad Sci U S A., 104(49):19541-6
Fradet-Turcotte A, Vincent C, Joubert S, Bullock PA, Archambault J. (2007) A Quantitative Analysis of the Binding of Simian Virus 40 Large T Antigen to DNA. J. Virol., 81(17):9162-74
Kumar A, Meinke G, Reese DK, Moine S, Phelan PJ, Fradet-Turcotte A, Archambault J, Bohm A, Bullock PA. (2007) A model for T-antigen dependent melting of the Simian Virus 40 Core Origin based on studies of the interaction of the beta-hairpin with DNA. J. Virol., 81(9):4808-18
Fradet-Turcotte A, and Archambault J. (2007) Recent advances in the search for antiviral agents against human papillomavirus. Antiviral therapy. 12(4):431-51
Nous sommes toujours à la recherche d’étudiants(es) motivés(ées) qui désirent poursuivre des études aux cycles supérieurs (Maîtrise et/ou Doctorat). Si vous êtes intéressé(ée) à étudier les mécanismes assurant le maintien de la stabilité génomique dans le contexte d’une infection virale, veuillez nous faire parvenir une lettre de motivation ainsi que votre CV.
Adresse : Centre de recherche du CHU de Québec Centre de recherche en cancer de l'Université Laval 9 McMahon Québec, QC G1R 2J6 CANADA
Courriel : amelie.fradet.turcotte@gmail.com
Site Web : http://www.aftlab.ca